Status:
COMPLETED
MOST EMPOWER: Optimizing An Emotion Regulation Intervention
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Eligibility:
All Genders
15-39 years
Phase:
NA
Brief Summary
This purpose of this study is to test a digital health intervention that may promote well-being among young adult cancer survivors. Investigators hope to learn more about wellness and health-related q...
Detailed Description
The EMPOWER Intervention is composed of five components: 1. Noting daily positive event, capitalizing on and savoring positive events, and gratitude. 2. Mindfulness 3. Positive Reappraisal 4. Focusin...
Eligibility Criteria
Inclusion
- Able to read and understand English
- Past history of a cancer diagnosis (excluding basal cell skin carcinoma)
- 15 to 39 years of age at diagnosis of first cancer and currently between the ages of 15 to 39
- Within 0-5 year's post-active treatment for initial diagnosis or recurrence (Note: Maintenance therapy for hematologic or hormonal therapy for breast cancers are not considered "active treatments" for purposes of this study).
- Internet access through a home computer, tablet or smartphone.
Exclusion
- Ever been hospitalized for a psychiatric illness
- Currently receiving palliative or hospice care
Key Trial Info
Start Date :
January 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
352 Patients enrolled
Trial Details
Trial ID
NCT04317417
Start Date
January 6 2022
End Date
April 30 2025
Last Update
September 18 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States, 60611
2
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States, 27157
3
MD Anderson Cancer Center
Houston, Texas, United States, 77030